Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03991507

PCOS (Polycystic Ovarian Syndrome) Patients

The Prospective Cohort Study for PCOS Patients was set up to investigate the short- and long-term health consequences in Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, China.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year–40 year

Sex eligibility

Female

Study type

Observational

Primary location

Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, 450052, China

Location status: Recruiting

Location contact

Zhiqin Bu, M.D.

CONTACT

[email protected]

15981978863

About this study

Polycystic ovary syndrome (PCOS) affects 8-13% of women. It is a multifaceted condition characterized by chronic anovulation and excess ovarian activity.

Since last decade, Clinical Reproductive Medicine Management System/Electronic Medical Record Cohort Database (CCRM/EMRCD) has been used in Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, and Henan Province Key Laboratory for Reproduction and Genetics. Information of patients (POI, PCOS, Endometriosis, azoospermia, ect) were recorded comprehensively. The current project plans to recruit PCOS participants in our center. Biological samples, questionnaires and short/long term health data will be collected. The study is aimed to provide evidence for PCOS prognosis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • PCOS patients diagnosed with The Rotterdam diagnostic criteria.

Exclusion criteria

-

Treatment and study plan

Primary outcomes

  1. Level of serum FSH (Follicle stimulating hormone)

    Time frame: From date of inclusion, assessed by each 12 month, up to 40 years

    mIU/mL

  2. Level of serum LH (Luteinizing hormone)

    Time frame: From date of inclusion, assessed by each 12 month, up to 40 years

    mIU/mL

  3. Level of T (Testosterone)

    Time frame: From date of inclusion, assessed by each 12 month, up to 40 years

    ng/ml

Secondary outcomes

  1. Body Weight

    Time frame: From date of inclusion, assessed by each 12 month, up to 40 years

    Recorded in Kilograms

  2. Height

    Time frame: From date of inclusion, assessed by each 12 month, up to 40 years

    Recorded in centimeters

Study contacts

Contact information is provided by the study sponsor or research team.

Lanlan Fang, M.D.

CONTACT

[email protected]

13673355291

Sponsors and collaborators

Lead sponsor

The First Affiliated Hospital of Zhengzhou University

Other

Registry information

Official study title

Prospective Cohort Study for PCOS Patients in Clinical Reproductive Medicine Management System/Electronic Medical Record Cohort Database (CCRM/EMRCD)

Important dates

Study start
2010
Primary completion
2050
Study completion
2050
First posted
Jun 19, 2019
Registry last updated
Jun 19, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.